Breaking News


Efficacy and safety of MASO63DP cream in pediatric atopic dermatitis


A 6-week multicenter, double-blind, vehicle-controlled study assessed the effects of MASO63DP nonsteroidal cream or vehicle in 142 children aged 6 months to 12 years with mild to moderate atopic dermatitis (AD). Primary outcomes included the Investigators' Global Assessment (IGA) of body surface area (BSA) affected at day 22 and an itch score measured by visual analogue scale (VAS). Patients were assessed at baseline and on days 3, 8, 15, 22, 29 and 43. The majority of MASO63DP patients (76.8%) achieved an IGA score of 0 or 1 (clear or almost clear) at day 22 versus 0% in vehicle treated patients (p<0.0001). Itch was significantly reduced on the VAS at all time ...

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here

return to breaking news list